Pain
Conference Coverage
Patients remain satisfied despite reduced use of opioids post partum
GRAPEVINE, TEX. – At one center, trends in opioid use significantly declined from 2017 to 2019, but not at the expense of adequate pain control,...
Conference Coverage
IBD quality initiative slashes ED utilization
A quality initiative led to sharp drops in emergency department visits, hospitalizations, and opioid use for Crohn’s and ulcerative colitis...
News from the FDA/CDC
CDC: Opioid prescribing and use rates down since 2010
News
FDA advisers set high bar for new opioids
Two days of FDA discussion over three new opioids seeking U.S. approval highlighted the barriers these drugs now face.
News from the FDA/CDC
FDA committee rejects oxycodegol, new opioid designed for less abuse
A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.
Conference Coverage
In addiction, abusive partners can wreak havoc
SAN DIEGO – Strategies of abusive partners include sabotaging and discrediting their partners’ attempts at recovery, Dr. Carole Warshaw said.
News
Survey: Cancer-related pain, opioid use up since 2018
Almost half of patients with cancer did not use anything to manage related symptoms, according to an ASCO poll.
Conference Coverage
OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factors
ATLANTA – “For any individual patient, a single option may be chosen at a particular time point, perhaps with or without other options, and may be...
Conference Coverage
Elagolix is effective second-tier treatment for endometriosis-associated dysmenorrhea
PHILADELPHIA – It has a very low adverse event profile and is well tolerated.
Conference Coverage
Cannabis frequently is used for endometriosis pain
VANCOUVER, B.C. – Survey finds more than a third of patients have used marijuana or CBD, and some find it effective...